Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 07 Feb 2023

Sex and gender differences in the use of oral anticoagulants for non-valvular atrial fibrillation: A population-based cohort study in primary health care in catalonia

in Pharmacoepidemiology

Maria Giner-Soriano
Oriol Prat-Vallverdú
Dan Ouchi
Carles Vilaplana-Carnerero
Rosa Morros

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1110036

4,358 views
17 citations

Original Research

Published on 06 Feb 2023

First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil

in Pharmacoepidemiology

Ranailla Lima Bandeira dos Santos
Claudia Garcia Serpa Osorio-de-Castro
Mario Jorge Sobreira-da-Silva
Vera Lúcia Edais Pepe

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1069505

2,552 views
1 citation

Original Research

Published on 30 Jan 2023

Characteristics of drug safety alerts issued by the Spanish Medicines Agency

in Pharmacoepidemiology

Eva Montané
Javier Santesmases

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090707

4,039 views
5 citations

Original Research

Published on 26 Jan 2023

Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

in Pharmacoepidemiology

Yu-Yang Liu
Yi-Yang Qu
Shang Wang
Ci-Jun Luo
Hong-Ling Qiu
Hui-Ting Li
Ping Yuan
Lan Wang
Jin-Ling Li
Rong Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1052546

6,530 views
2 citations

Brief Research Report

Published on 17 Jan 2023

Drug utilization research in Peru: Is real-world data available?

in Pharmacoepidemiology

L. Yesenia Rodríguez-Tanta
Héctor Garavito Farro
Lisiane Freitas Leal
Maribel Salas
Monique M. Elseviers
Luciane Cruz Lopes

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1047946

5,961 views
7 citations

Original Research

Published on 12 Jan 2023

Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China

in Pharmacoepidemiology

Qiyou Wu
Zhiwei Lian
Xin Wang
Hanchao Cheng
Jing Sun
Hui Yu
Gong Zhang
Fan Wu
Jian Liu
Chuanben Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1044798

3,556 views
7 citations

Original Research

Published on 12 Jan 2023

Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study

in Pharmacoepidemiology

Cheng-Yu Tsai
Chuan-Wei Shen
Hsuan-Lin Lai
Chung-Yu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1030693

6,169 views
11 citations

Original Research

Published on 12 Jan 2023

Association between glucocorticoid use and all-cause mortality in critically ill patients with heart failure: A cohort study based on the MIMIC-III database

in Pharmacoepidemiology

Jia-Liang Zhu
Liang Hong
Shi-Qi Yuan
Xiao-Mei Xu
Jian-Rui Wei
Hai-Yan Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118551

5,085 views
1 citation

Original Research

Published on 10 Jan 2023

Potentially inappropriate medication use and associated factors in residents of long-term care facilities: A nationwide cohort study

in Pharmacoepidemiology

Suhyun Jang
Young-Mi Ah
Sunmee Jang
Yeji Kim
Ju-Yeun Lee
Jung-Ha Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1092533

3,723 views
5 citations

Original Research

Published on 06 Jan 2023

Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study

in Pharmacoepidemiology

Xiaoying Zhang
Yuyao Liu
Yanghui Ou
Man Yang
Jinqiu Yuan
Qiangsheng He
Yanfei Li
Ningning Mi
Peng Xie
Wenjing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1044542

8,162 views
2 citations

Original Research

Published on 05 Jan 2023

Transparency of data on the value chain of medicines in Argentina, Brazil, and Colombia

in Pharmacoepidemiology

Alane Andrelino Ribeiro
Angela Acosta
Marcela Amaral Pontes
Manuel Alejandro Machado Beltran
Rafaela Tavares Peixoto
Silvana Nair Leite

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063300

17,143 views
6 citations

Review

Published on 04 Jan 2023

Comparative differences in the risk of major gastrointestinal bleeding among different direct oral anticoagulants: An updated traditional and Bayesian network meta-analysis

in Pharmacoepidemiology

Xiuehui Chen
Lili Wang
Huijun Li
Weichao Huang
Lingyue Zhao
Wenqin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1049283

13,464 views
15 citations

Brief Research Report

Published on 23 Dec 2022

Dispensing of psychotropic drugs in the Brazilian capital city before and during the COVID-19 pandemic (2018–2020)

in Pharmacoepidemiology

Pamela Alejandra Escalante Saavedra
Dayani Galato
Calliandra Maria de Souza Silva
Izabel Cristina Rodrigues da Silva
Emília Vitoria da Silva

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1028233

5,517 views
14 citations

Original Research

Published on 21 Dec 2022

Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis

in Pharmacoepidemiology

Fu-Shun Yen
Ming-Chih Hou
James Cheng-Chung Wei
Ying-Hsiu Shih
Chung Y. Hsu
Chih-Cheng Hsu
Chii-Min Hwu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1049094

4,305 views
6 citations

Original Research

Published on 08 Dec 2022

Plasma apixaban levels in Chinese patients with chronic kidney disease—Relationship with renal function and bleeding complications

in Pharmacoepidemiology

Chun-fung Sin
Ka-ping Wong
Tsz-fu Wong
Chung-wah Siu
Desmond Y. H. Yap

Frontiers in Pharmacology

doi 10.3389/fphar.2022.928401

2,795 views
3 citations

Original Research

Published on 07 Dec 2022

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic

in Pharmacoepidemiology

Elena Olmastroni
Federica Galimberti
Alberico L. Catapano
Elena Tragni
Manuela Casula

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1040710

3,661 views
2 citations

Review

Published on 01 Dec 2022

Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review

in Pharmacoepidemiology

Seth Kwabena Amponsah
Benjamin Tagoe
Ismaila Adams
Kwasi Agyei Bugyei

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063246

9,683 views
14 citations

Original Research

Published on 30 Nov 2022

Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study

in Pharmacoepidemiology

Estela Pineda
Jarmanjeet Singh
Miguel Vargas Pineda
Jose Garay Umanzor
Fernando Baires
Luis G. Benitez
Cesar Burgos
Anupamjeet Kaur Sekhon
Nicole Crisp
Anita S. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054644

5,428 views
7 citations

Original Research

Published on 29 Nov 2022

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database

in Pharmacoepidemiology

Shuang Zhou
Boying Jia
Jiahe Kong
Xiaolin Zhang
Lili Lei
Zhenhui Tao
Lingyue Ma
Qian Xiang
Ying Zhou
Yimin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1044744

12,531 views
40 citations

Original Research

Published on 25 Nov 2022

The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition

in Pharmacoepidemiology

GYeon Oh
Daniela C. Moga
David W. Fardo
Erin L. Abner

Frontiers in Pharmacology

doi 10.3389/fphar.2022.910719

58,773 views
25 citations

Correction

Published on 24 Nov 2022

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs

in Pharmacoepidemiology

Martijn J. Schuemie
Faaizah Arshad
Nicole Pratt
Fredrik Nyberg
Thamir M Alshammari
George Hripcsak
Patrick Ryan
Daniel Prieto-Alhambra
Lana Y. H. Lai
Xintong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1088973

1,639 views

Original Research

Published on 24 Nov 2022

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

in Pharmacoepidemiology

Sophie H. Bots
Judit Riera-Arnau
Svetlana V. Belitser
Davide Messina
Maria Aragón
Ema Alsina
Ian J. Douglas
Carlos E. Durán
Patricia García-Poza
Rosa Gini

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1038043

11,125 views
28 citations

Original Research

Published on 24 Nov 2022

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

in Pharmacoepidemiology

Ya-Hui Yu
In-Sun Oh
Han Eol Jeong
Robert W. Platt
Antonios Douros
Ju-Young Shin
Kristian B. Filion

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1034636

2,910 views
2 citations

Original Research

Published on 24 Nov 2022

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

in Pharmacoepidemiology

J. Barceló-Vidal
D. Echeverría-Esnal
N. Carballo
M. De Antonio-Cuscó
X. Fernández-Sala
M. E. Navarrete-Rouco
E. Colominas-González
S. Luque
M. Fuster-Esteva
L. Domingo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993158

4,044 views
4 citations

601 articles

articles

Sex and gender differences in the use of oral anticoagulants for non-valvular atrial fibrillation: A population-based cohort study in primary health care in catalonia

First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil

Characteristics of drug safety alerts issued by the Spanish Medicines Agency

Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Drug utilization research in Peru: Is real-world data available?

Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China

Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study

Association between glucocorticoid use and all-cause mortality in critically ill patients with heart failure: A cohort study based on the MIMIC-III database

Potentially inappropriate medication use and associated factors in residents of long-term care facilities: A nationwide cohort study

Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study

Transparency of data on the value chain of medicines in Argentina, Brazil, and Colombia

Comparative differences in the risk of major gastrointestinal bleeding among different direct oral anticoagulants: An updated traditional and Bayesian network meta-analysis

Dispensing of psychotropic drugs in the Brazilian capital city before and during the COVID-19 pandemic (2018–2020)

Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis

Plasma apixaban levels in Chinese patients with chronic kidney disease—Relationship with renal function and bleeding complications

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic

Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review

Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database

The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic